# Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia

> **NCT00719420** · PHASE3 · COMPLETED · sponsor: **University of North Texas Health Science Center** · enrollment: 151 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Clarithromycin, Metronidazole, Amoxicillin (+Omeprazole)
- **DRUG:** Clarithromycin, Amoxicillin, Omeprazole

## Key facts

- **NCT ID:** NCT00719420
- **Lead sponsor:** University of North Texas Health Science Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2008-07-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00719420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00719420, "Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00719420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*